NM_024321.5:c.473G>A

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM1BP4_Strong

The NM_024321.5(RBM42):​c.473G>A​(p.Arg158His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000071 in 1,606,252 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.00013 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000065 ( 0 hom. )

Consequence

RBM42
NM_024321.5 missense

Scores

3
2
14

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 3.13

Publications

2 publications found
Variant links:
Genes affected
RBM42 (HGNC:28117): (RNA binding motif protein 42) Enables RNA binding activity. Predicted to act upstream of or within negative regulation of mRNA splicing, via spliceosome. Predicted to be located in cytoplasm and nucleus. Predicted to be part of ribonucleoprotein complex. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

PM1
In a modified_residue Asymmetric dimethylarginine (size 0) in uniprot entity RBM42_HUMAN
BP4
Computational evidence support a benign effect (MetaRNN=0.037353784).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RBM42NM_024321.5 linkc.473G>A p.Arg158His missense_variant Exon 5 of 10 ENST00000262633.9 NP_077297.2 Q9BTD8-1
RBM42NM_001319113.2 linkc.443-132G>A intron_variant Intron 4 of 8 NP_001306042.1 Q9BTD8-3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RBM42ENST00000262633.9 linkc.473G>A p.Arg158His missense_variant Exon 5 of 10 1 NM_024321.5 ENSP00000262633.3 Q9BTD8-1

Frequencies

GnomAD3 genomes
AF:
0.000126
AC:
19
AN:
151362
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000341
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000737
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000684
AC:
17
AN:
248628
AF XY:
0.0000669
show subpopulations
Gnomad AFR exome
AF:
0.000619
Gnomad AMR exome
AF:
0.0000294
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000445
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000653
AC:
95
AN:
1454772
Hom.:
0
Cov.:
31
AF XY:
0.0000718
AC XY:
52
AN XY:
723862
show subpopulations
African (AFR)
AF:
0.000752
AC:
25
AN:
33262
American (AMR)
AF:
0.0000678
AC:
3
AN:
44244
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25924
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39464
South Asian (SAS)
AF:
0.0000116
AC:
1
AN:
85886
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53392
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5718
European-Non Finnish (NFE)
AF:
0.0000560
AC:
62
AN:
1106804
Other (OTH)
AF:
0.0000666
AC:
4
AN:
60078
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.461
Heterozygous variant carriers
0
6
12
17
23
29
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000125
AC:
19
AN:
151480
Hom.:
0
Cov.:
32
AF XY:
0.000122
AC XY:
9
AN XY:
73982
show subpopulations
African (AFR)
AF:
0.000340
AC:
14
AN:
41206
American (AMR)
AF:
0.00
AC:
0
AN:
15242
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5148
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4778
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10490
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000737
AC:
5
AN:
67846
Other (OTH)
AF:
0.00
AC:
0
AN:
2098
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000178
Hom.:
0
Bravo
AF:
0.000140
ExAC
AF:
0.0000906
AC:
11

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Mar 18, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.473G>A (p.R158H) alteration is located in exon 5 (coding exon 5) of the RBM42 gene. This alteration results from a G to A substitution at nucleotide position 473, causing the arginine (R) at amino acid position 158 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.80
BayesDel_addAF
Benign
-0.38
T
BayesDel_noAF
Benign
-0.43
CADD
Uncertain
24
DANN
Pathogenic
1.0
DEOGEN2
Benign
0.11
T
Eigen
Benign
-0.055
Eigen_PC
Benign
0.10
FATHMM_MKL
Pathogenic
0.97
D
LIST_S2
Benign
0.76
T
M_CAP
Benign
0.011
T
MetaRNN
Benign
0.037
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.6
L
PhyloP100
3.1
PrimateAI
Uncertain
0.68
T
PROVEAN
Benign
-1.8
N
REVEL
Benign
0.13
Sift
Uncertain
0.028
D
Sift4G
Benign
0.16
T
Polyphen
0.0
B
Vest4
0.30
MVP
0.15
MPC
0.97
ClinPred
0.11
T
GERP RS
4.2
Varity_R
0.12
gMVP
0.19
Mutation Taster
=90/10
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs78375138; hg19: chr19-36123868; COSMIC: COSV99386921; COSMIC: COSV99386921; API